Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tailored treatment of functional dyspepsia with nortriptyline (TENDER)
2017-003307-21Phase 3Terminated
- Sponsor
- Maastricht University
- Start
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in functional dyspepsia (FD) comparing Nortriptyline arm with Placebo arm (2 arms). Primary endpoint: Primary response to therapy. Started Dec 2017; status: terminated.
02
Drugs
nortriptyline
03
Conditions
functional dyspepsia (FD)
Beyond the preview
Go deeper on 2017-003307-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-003307-21.